Kathy Medvik

1.8k total citations
17 papers, 1.5k citations indexed

About

Kathy Medvik is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Kathy Medvik has authored 17 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 10 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in Kathy Medvik's work include HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (9 papers) and Immune Cell Function and Interaction (8 papers). Kathy Medvik is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS Research and Interventions (9 papers) and Immune Cell Function and Interaction (8 papers). Kathy Medvik collaborates with scholars based in United States, Sweden and Switzerland. Kathy Medvik's co-authors include Michael M. Lederman, Robert Asaad, Hernán Valdez, Scott F. Sieg, Christoph Lange, Robert C. Kalayjian, Héctor R. Rangel, Jan Weber, Bikram Chakraborty and Michael Marotta and has published in prestigious journals such as Blood, The Journal of Infectious Diseases and PLoS Medicine.

In The Last Decade

Kathy Medvik

17 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kathy Medvik United States 12 944 620 574 427 249 17 1.5k
Megan Mefford United States 14 928 1.0× 641 1.0× 522 0.9× 265 0.6× 162 0.7× 14 1.6k
Elizabeth Reay United States 11 1.4k 1.5× 903 1.5× 691 1.2× 476 1.1× 43 0.2× 14 1.8k
Stephen P. Blatt United States 15 818 0.9× 826 1.3× 422 0.7× 520 1.2× 46 0.2× 27 1.7k
Krista L. Dong United States 14 562 0.6× 370 0.6× 543 0.9× 460 1.1× 491 2.0× 44 1.3k
Alain Lafeuillade France 24 1.2k 1.2× 259 0.4× 1.1k 1.9× 368 0.9× 71 0.3× 89 1.7k
Berta Rodés Spain 27 1.1k 1.1× 317 0.5× 1.0k 1.8× 641 1.5× 149 0.6× 62 2.0k
Moraima Guadalupe United States 13 1000 1.1× 645 1.0× 570 1.0× 468 1.1× 33 0.1× 13 1.6k
Kathie Grovit‐Ferbas United States 14 894 0.9× 549 0.9× 464 0.8× 306 0.7× 44 0.2× 15 1.2k
Lucy Dorrell United Kingdom 28 1.3k 1.4× 1.2k 1.9× 651 1.1× 679 1.6× 54 0.2× 87 2.5k
Nicole Galloway United States 7 586 0.6× 594 1.0× 289 0.5× 237 0.6× 61 0.2× 7 1.3k

Countries citing papers authored by Kathy Medvik

Since Specialization
Citations

This map shows the geographic impact of Kathy Medvik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Medvik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Medvik more than expected).

Fields of papers citing papers by Kathy Medvik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Medvik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Medvik. The network helps show where Kathy Medvik may publish in the future.

Co-authorship network of co-authors of Kathy Medvik

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Medvik. A scholar is included among the top collaborators of Kathy Medvik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Medvik. Kathy Medvik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Anthony, Donald D., Kathy Medvik, M.R. Sandhya Rani, et al.. (2012). Baseline Levels of Soluble CD14 and CD16+56− Natural Killer Cells Are Negatively Associated With Response to Interferon/Ribavirin Therapy During HCV-HIV-1 Coinfection. The Journal of Infectious Diseases. 206(6). 969–973. 14 indexed citations
2.
Anthony, Donald D., Triin Umbleja, Judith A. Aberg, et al.. (2011). Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals. Vaccine. 29(19). 3558–3563. 15 indexed citations
4.
Lederman, Michael M., Leonard H. Calabrese, Nicholas Funderburg, et al.. (2011). Immunologic Failure Despite Suppressive Antiretroviral Therapy Is Related to Activation and Turnover of Memory CD4 Cells. The Journal of Infectious Diseases. 204(8). 1217–1226. 254 indexed citations
5.
Gandhi, Rajesh T., Lu Zheng, Ronald J. Bosch, et al.. (2010). The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial. PLoS Medicine. 7(8). e1000321–e1000321. 242 indexed citations
6.
McComsey, Grace A., Ulrich A. Walker, Chakra Budhathoki, et al.. (2010). Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229. AIDS. 24(16). 2507–2515. 20 indexed citations
7.
Rodríguez, Benigno, Hernán Valdez, Christoph Lange, et al.. (2010). In vitro naïve T cell proliferation failure predicts poor post-immunization responses to neoantigen, but not recall antigens, in HIV-infection. Clinical Immunology. 136(3). 400–408. 7 indexed citations
8.
Pilch-Cooper, Heather A., Scott F. Sieg, Thomas J. Hope, et al.. (2010). Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5. Blood. 118(4). 1015–1019. 5 indexed citations
9.
Sereti, Irini, Richard M. Dunham, John Spritzler, et al.. (2009). IL-7 administration drives T cell–cycle entry and expansion in HIV-1 infection. Blood. 113(25). 6304–6314. 263 indexed citations
10.
Lederman, Michael M., Laura Smeaton, Benigno Rodríguez, et al.. (2006). Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV‐1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138. The Journal of Infectious Diseases. 194(12). 1677–1685. 31 indexed citations
11.
Lange, Christoph, Zhan Xu, Bruce K. Patterson, et al.. (2004). Proliferation responses to HIVp24 during antiretroviral therapy do not reflect improved immune phenotype or function. AIDS. 18(4). 605–613. 13 indexed citations
12.
Lange, Christoph, Michael M. Lederman, Kathy Medvik, et al.. (2003). Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection. AIDS. 17(14). 2015–2023. 146 indexed citations
13.
Quiñones‐Mateu, Miguel E., Michael M. Lederman, Zhimin Feng, et al.. (2003). Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication. AIDS. 17(16). F39–F48. 354 indexed citations
14.
Lange, Christoph, Hernán Valdez, Kathy Medvik, Robert Asaad, & Michael M. Lederman. (2002). CD4+ T-Lymphocyte Nadir and the Effect of Highly Active Antiretroviral Therapy on Phenotypic and Functional Immune Restoration in HIV-1 Infection. Clinical Immunology. 102(2). 154–161. 81 indexed citations
15.
Lange, Christoph, Michael M. Lederman, Juan Sierra Madero, et al.. (2002). Impact of Suppression of Viral Replication by Highly Active Antiretroviral Therapy on Immune Function and Phenotype in Chronic HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 30(1). 33–40. 28 indexed citations
16.
Lange, Christoph, Michael M. Lederman, Juan Sierra Madero, et al.. (2002). Impact of Suppression of Viral Replication by Highly Active Antiretroviral Therapy on Immune Function and Phenotype in Chronic HIV-1 Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 30(1). 33–40. 2 indexed citations
17.
Baley, Jill E., Margaret C. Bruce, E.K. Stork, et al.. (1990). Granulocyte transfusions in septic adult and newborn rats: distribution of granulocytes and effect on peripheral blood and bone marrow.. PubMed. 115(3). 283–91. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026